The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
Open accessAbstract
Kidney disease affects over 20 million people in the United States alone. Although the causes of renal failure are diverse, the glomerular filtration barrier is often the target of injury. Dysregulation of VEGF expression within the glomerulus has been demonstrated in a wide range of primary and acquired renal diseases, although the significance of these changes is unknown. In the glomerulus, VEGF-A is highly expressed in podocytes that make up a major portion of the barrier between the blood and urinary spaces. In this paper, we show that glomerular-selective deletion or overexpression of VEGF-A leads to glomerular disease in mice. Podocyte-specific heterozygosity for VEGF-A resulted in renal disease by 2.5 weeks of age, characterized by proteinuria and endotheliosis, the renal lesion seen in preeclampsia. Homozygous deletion of VEGF-A in glomeruli resulted in perinatal lethality. Mutant kidneys failed to develop a filtration barrier due to defects in endothelial cell migration, differentiation, and survival. In contrast, podocyte-specific overexpression of the VEGF-164 isoform led to a striking collapsing glomerulopathy, the lesion seen in HIV-associated nephropathy. Our data demonstrate that tight regulation of VEGF-A signaling is critical for establishment and maintenance of the glomerular filtration barrier and strongly supports a pivotal role for VEGF-A in renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Self-citationPodocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Roberts, W. G., & Palade, G. E. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2369 · Cited by 1,033
Saxen, L. (1987) · Cambridge University Press eBooks · doi:10.1017/cbo9780511565083 · Cited by 1,030
VEGF is required for growth and survival in neonatal mice
Gerber, H.-P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 915
Self-citationNovak, A., Guo, C., Yang, W., Nagy, A., & Lobe, C. G. (2000) · genesis · doi:10.1002/1526-968x(200011/12)28:3/4<147::aid-gene90>3.0.co;2-g · Cited by 844
Self-citationVascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro
Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T., & Risau, W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.947 · Cited by 648
BARISONI, L., KRIZ, W., MUNDEL, P., & D'AGATI, V. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10151 · Cited by 557
Bachelder, R. E., Crago, A. M., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G. S., & Mercurio, A. M. (2001) · PubMed · Cited by 487
Shahbazi, M., Fryer, A. A., Pravica, V., Brogan, I. J., Ramsay, H. M., Hutchinson, I. V., & Harden, P. N. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131260 · Cited by 412
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
Coimbra, T. M., Janssen, U., Gröne, H. J., Ostendorf, T., Kunter, U., Schmidt, H., Brabant, G., & Floege, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00836.x · Cited by 377
Early organogenesis of the kidney
Sax�n, L., & Sariola, H. (1987) · Pediatric Nephrology · doi:10.1007/bf00849241 · Cited by 366
Drake, C. J., & Little, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7657 · Cited by 324
Marras, D., Bruggeman, L. A., Gao, F., Tanji, N., Mansukhani, M. M., Cara, A., Ross, M. D., Gusella, G. L., Benson, G., D'Agati, V. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-522 · Cited by 303
Kitamoto, Y., Tokunaga, H., & Tomita, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119416 · Cited by 294
VEGF165 mediates glomerular endothelial repair
Ostendorf, T., Kunter, U., Eitner, F., Loos, A., Regele, H., Kerjaschki, D., Henninger, D. D., Janjic, N., & Floege, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6740 · Cited by 287
Multiple Developmental Roles of VEGF Suggested by a LacZ-Tagged Allele
Miquerol, L., Gertsenstein, M., Harpal, K., Rossant, J., & Nagy, A. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9355 · Cited by 281
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Miner, J. H., & Li, C. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9546 · Cited by 270
Self-citationNephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.
Bruggeman, L. A., Dikman, S., Meng, C., Quaggin, S. E., Coffman, T. M., & Klotman, P. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119525 · Cited by 247
Self-citationKim, Y.-G., Suga, S.-I., Kang, D.-H., Jefferson, J. A., Mazzali, M., Gordon, K. L., Matsui, K., Breiteneder-Geleff, S., Shankland, S. J., Hughes, J., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00422.x · Cited by 208
Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165
Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., & Ron, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10816 · Cited by 182
Neuroimaging Findings in Twins Discordant for Alzheimer’s Disease
Pedersen, N. L., Miller, B. L., Loebach Wetherell, J., Vallø, J., Toga, A. W., Knutson, N., Mehringer, C. M., Small, G. W., & Gatz, M. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017097 · Cited by 180
Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study
Laurinavicius, A., Hurwitz, S., & Rennke, H. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00769.x · Cited by 176
The role of the podocyte in glomerulosclerosis
Kriz, W., & Lemley, K. V. (1999) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-199907000-00014 · Cited by 160
HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes
Husain, M., Gusella, G. L., Klotman, M. E., Gelman, I. H., Ross, M. D., Schwartz, E. J., Cara, A., & Klotman, P. E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019642.55998.69 · Cited by 145
Role of vascular endothelial growth factor in diabetic nephropathy
Cha, D. R., Kim, N. H., Yoon, J., Jo, S., Cho, W. Y., Kim, H. K., & Won, N. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07717.x · Cited by 142
Floege, J., Hackmann, B., Kliem, V., Kriz, W., Alpers, C. E., Johnson, R. J., Kühn, K. W., Koch, K. M., & Brunkhorst, R. (1997) · Kidney International · doi:10.1038/ki.1997.28 · Cited by 136
Ganju, R. K., Munshi, N., Nair, B. C., Liu, Z., Gill, P. S., & Groopman, J. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.6131-6137.1998 · Cited by 116
Glomerulogenesis in the developing kidney.
Abrahamson, D. R. (1991) · PubMed · Cited by 113
Mattot, V., Moons, L., Lupu, F., Cherñavvsky, D. R., Gómez, R. A., Collen, D., & Carmeliet, P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013925.19218.7b · Cited by 109
Glomerular-Specific Gene Excision In Vivo
Eremina, V., Wong, M. A., Cui, S., Schwartz, L., & Quaggin, S. E. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133788 · Cited by 101
Self-citationCoexpression of neuropilin-1, Flk1, and VEGF164in developing and mature mouse kidney glomeruli
Robert, B., Zhao, X., & Abrahamson, D. R. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.2.f275 · Cited by 101
Identification and characterization of a glomerular-specific promoter from the human nephrin gene
Wong, M. A., Cui, S., & Quaggin, S. E. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.6.f1027 · Cited by 80
Self-citationThe Renal Lesion of Preeclampsia Revisited
Kincaid-Smith, P. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)81119-x · Cited by 77
Shirato, I., Hosser, H., Kriz, W., Kimura, K., Sakai, T., & Tomino, Y. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00198342 · Cited by 57
HIV-Tat dependent chemotaxis and invasion, key aspects of Tat mediated pathogenesis
Venè, R., Benelli, R., Noonan, D. M., & Albini, A. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1011991906685 · Cited by 27
Cited by
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Self-citationCirculating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Self-citationDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
“VEGF inhibition during the early neonatal period results in growth arrest, endothelial-cell apoptosis and lethality, due primarily to kidney failur”
BackgroundSelf-citationPhenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750
Metadata
- Authors
- Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-03-01
- Volume
- 111
- Issue
- 5
- Pages
- 707-716
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2150893441
- Cited by
- 1,313
- References
- 40
- FWCI
- 33.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.